Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amarox Pharma is a pharmaceutical company headquartered in the United Kingdom, serving as the European commercial subsidiary of the global pharmaceutical giant Hetero Labs Limited. The company specializes in the development, manufacturing, and distribution of high-quality generic medicines, complex generics, and biosimilars. Amarox's extensive portfolio covers critical therapeutic areas such as oncology, HIV/AIDS, cardiovascular health, and central nervous system disorders. By leveraging Hetero's robust vertical integration and world-class manufacturing facilities, Amarox ensures a reliable supply of affordable treatments to the National Health Service (NHS) and other European healthcare providers. The company is committed to expanding its presence through strategic partnerships and a growing pipeline of value-added medicines. Their operations are supported by a strong focus on regulatory compliance and patient-centric healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amarox Pharma Global.